CompletedPHASE1, PHASE2NCT02055456

Nandrolone Decanoate in the Treatment of Telomeropathies

Studying Aplastic Anemia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University of Sao Paulo
Principal Investigator
Rodrigo T Calado, MD, PhD
Ribeirao Preto School of Medicine at University of Sao Paulo
Intervention
Nandrolone Decanoate(drug)
Enrollment
20 enrolled
Eligibility
2-99 years · All sexes
Timeline
20142017

Study locations (1)

Collaborators

Conselho Nacional de Desenvolvimento Científico e Tecnológico

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02055456 on ClinicalTrials.gov

Other trials for Aplastic Anemia

Additional recruiting or active studies for the same condition.

See all trials for Aplastic Anemia

← Back to all trials